UOCPC23054 / GAM-CRT / Mohile
Basic Study Information
Purpose:
This clinical trial tests how well a geriatric assessment (GA) with GA-directed treatment
recommendations, compared to GA with usual care, works in identifying risk factors,
reducing chemotherapy radiation toxicity and functional decline, and improving the
overall quality of life in older patients with non-small cell lung cancer (NSCLC).
Older patients with lung cancer undergoing chemotherapy are at an increased risk of
adverse outcomes including treatment toxicity and functional and physical consequences.
This makes it very challenging for the physicians to balance the benefits against
the risk of chemotherapy in older cancer patients. A geriatric assessment may be useful
in identifying risk factors for chemotherapy radiation toxicity. Communicating these
geriatric assessment findings and assessment-based recommendations to a patient's
treating physicians may help them make more informed decisions about treatment options
for patients. Making treatment decisions using GA-based recommendations may reduce
adverse events and improve outcomes in patients receiving treatment for NSCLC.
Location: University of Rochester
Lead Researcher (Principal Investigator)
Lead Researcher:
Supriya Mohile
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, Â鶹ÊÓƵ
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search